RHYTHM PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

RHYTHM PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $3.11 (loss) per share for the year ending 2025.

  • RHYTHM PHARMACEUTICALS, INC. showed an increase of +28.3% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from RHYTHM PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), RHYTHM PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 19.4%.
  • Historical annual values: Fiscal year 2025: $3.11 (loss) per share | Fiscal year 2024: $4.34 (loss) per share | Fiscal year 2023: $3.20 (loss) per share | Fiscal year 2022: $3.47 (loss) per share | Fiscal year 2021: $1.40 (loss) per share | Fiscal year 2020: $3.04 (loss) per share | Fiscal year 2019: $3.86 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: